Skip to main content

Advertisement

Log in

Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma

  • Case Report
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Myasthenia gravis (MG) and paraneoplastic cerebellar degeneration (PCD) are immune-mediated syndromes that can represent paraneoplastic disorders. We report a patient with history of ovarian carcinoma that presented with ptosis, diplopia and gait ataxia. Neurophysiological examination and laboratory tests revealed the presence of MG and PCD. An integrated FDG-PET/contrast-enhanced CT scan showed tumor recurrence. This is to the best of our knowledge the first association of MG and PCD with recurring ovarian carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Graus F, Dalmau J (2007) Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 20:732–737

    PubMed  Google Scholar 

  2. Lennon VA (1994) Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 44:2236–2240

    CAS  PubMed  Google Scholar 

  3. Giannopoulou C (2003) Navigating the paraneoplastic neurological syndromes. Eur J Nucl Med Mol Imag 30:333–338

    Article  Google Scholar 

  4. Posner JB (1991) Paraneoplastic syndromes. Neurol Clin 9:919–936

    CAS  PubMed  Google Scholar 

  5. Furneaux HM, Rosenblum MK, Dalmau J et al (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322:1844–1851

    Article  CAS  PubMed  Google Scholar 

  6. Shams’ili S, Grefkens J, de Leeuw B et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409–1418

    Article  PubMed  Google Scholar 

  7. Pittock SJ, Kryzer TJ, Lennon VA (2004) Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56(5):715–719

    Article  CAS  PubMed  Google Scholar 

  8. Mason WP, Graus F, Lang B, Honnorat J et al (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert–Eaton myasthenic syndrome. Brain 120:1279–1300

    Article  PubMed  Google Scholar 

  9. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A (2002) P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59:764–766

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Stefano Bartoletti for his technical supervision.

Conflict of interest statement

The authors declare no competing interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pietro Caliandro.

Additional information

P. Caliandro and M. Luigetti contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caliandro, P., Luigetti, M., Ricci, E. et al. Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. Neurol Sci 31, 79–81 (2010). https://doi.org/10.1007/s10072-009-0154-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-009-0154-3

Keywords

Navigation